Literature DB >> 17963144

Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).

Praneet Opanasopit1, Polawan Aumklad, Jarija Kowapradit, Tanasait Ngawhiranpat, Auayporn Apirakaramwong, Theerasak Rojanarata, Satit Puttipipatkhachorn.   

Abstract

The purpose of this study was to investigate the effect of molecular weight (MW) and salt forms of chitosans (aspartate; CS A, glutamate; CS G, lactate; CS L and hydrochloride, CS HCl) on the transepithelial electrical resistance (TEER) and permeability of Caco-2 cells monolayer, using fluorescein isothiocyanate dextran 4000 (FD-4) as the model compound for paracellular tight junction transport. Chitosan salts were prepared by spray-drying method. FTIR and solid-state (13)C NMR spectra showed the functional groups of salts in their molecular structures. Salt form, MW of chitosan, and amount of chitosan influenced the permeation-enhancing effects. These studies showed that chitosan salts appeared to increase cell permeability in a dose-dependent manner and caused relatively reversible effects only at the lower doses of 0.001-0.01% w/v. As the MW of chitosan increased from 20 to 460 kDa, the reduction in TEER significantly decreased in the following order: 20 < 45 < 200 < 460 kDa, observed in CS L and CS HCl. In CS A and CS G, the decrease in TEER was not significantly different in all MW because both chitosan salts showed rapid reduction in TEER within 20 min after the start of the experiment. Among chitosan salts, CS A was the most potent absorption enhancer in acidic (pH 6.2) environment. Cytotoxicity of chitosan salts was concentration dependent and varied slightly among the salt forms of chitosan used. CS HCl (MW 45 kDa) was the most toxic having an IC50 of 0.22 +/- 0.06 mg/mL. The ranking of chitosan salts cytotoxicity was CS HCl > CS L> CS G > CS A.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963144     DOI: 10.1080/10837450701555901

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  7 in total

Review 1.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

2.  In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  J Pharm Sci       Date:  2013-12-30       Impact factor: 3.534

3.  Methylated N-(4-N,N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2).

Authors:  Jariya Kowapradit; Praneet Opanasopit; Tanasait Ngawhiranpat; Auayporn Apirakaramwong; Theerasak Rojanarata; Uracha Ruktanonchai; Warayuth Sajomsang
Journal:  AAPS PharmSciTech       Date:  2008-11-14       Impact factor: 3.246

4.  Characterization of Different Salt Forms of Chitooligosaccharides and Their Effects on Nitric Oxide Secretion by Macrophages.

Authors:  Ronge Xing; Chaojie Xu; Kun Gao; Haoyue Yang; Yongliang Liu; Zhaoqian Fan; Song Liu; Yukun Qin; Huahua Yu; Pengcheng Li
Journal:  Molecules       Date:  2021-04-28       Impact factor: 4.411

5.  The Influence of Chitosan on the Oral Bioavailability of Acyclovir--a Comparative Bioavailability Study in Humans.

Authors:  Marlies Kubbinga; Mai Anh Nguyen; Petra Staubach; Steven Teerenstra; Peter Langguth
Journal:  Pharm Res       Date:  2015-01-22       Impact factor: 4.200

Review 6.  Chitosan-based mucosal adjuvants: Sunrise on the ocean.

Authors:  Yufei Xia; Qingze Fan; Dongxia Hao; Jie Wu; Guanghui Ma; Zhiguo Su
Journal:  Vaccine       Date:  2015-08-10       Impact factor: 3.641

Review 7.  Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment.

Authors:  Javad Sharifi-Rad; Cristina Quispe; Monica Butnariu; Lia Sanda Rotariu; Oksana Sytar; Simona Sestito; Simona Rapposelli; Muhammad Akram; Mehwish Iqbal; Akash Krishna; Nanjangud Venkatesh Anil Kumar; Susana S Braga; Susana M Cardoso; Karolina Jafernik; Halina Ekiert; Natália Cruz-Martins; Agnieszka Szopa; Marcelo Villagran; Lorena Mardones; Miquel Martorell; Anca Oana Docea; Daniela Calina
Journal:  Cancer Cell Int       Date:  2021-06-24       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.